Law 360

AUGUST 11, 2023

Illumina Inc. Securities and Exchange Commission is probing its 2020 reacquisition of Grail for $8 billion, including the conduct and pay of the companies' management. has revealed in a securities filing that the U.S.

40

40

Fordham Law News

NOVEMBER 18, 2022

In 2021, Illumina, Inc. Illumina”), a global genetic testing company, acquired GRAIL LLC (“Grail”), a healthcare start-up that develops early cancer detection tests based on sequencing technologies. [1] 1] Illumina formerly owned and has since retailed a minority interest in Grail. [2]

Administrative Law 52

Administrative Law Technology Healthcare Laws 52

Law 360

APRIL 13, 2023

Federal Trade Commission staffers urged the commissioners to ensure Illumina remains separate from Grail Inc. while the company appeals an order to unwind their merger, arguing that keeping their operations apart will spur competition from rival cancer tests.

40

40

Law 360

NOVEMBER 10, 2022

Biotechnology company Illumina Inc. told members of the Federal Trade Commission in a brief that the agency's in-house judge was right to reject the commission's challenge of its Grail Inc. acquisition, contending that the "lifesaving transaction" will revolutionize cancer screening.

40

40

Law 360

APRIL 5, 2023

Federal Trade Commission's order for Illumina Inc. to unwind its reacquisition of Grail, but said he remains concerned about the biotech company's future under CEO Francis deSouza, calling for his "immediate" removal. Activist investor Carl Icahn said Wednesday he is "not surprised" by the U.S.

40

40

Law 360

JUNE 3, 2022

Illumina urged a Delaware federal judge Friday to overturn a verdict last month finding that the biotechnology company willfully infringed two Complete Genomics Inc.

40

40

Law 360

NOVEMBER 2, 2021

Illumina Inc. told a New York federal judge Monday that a San Diego man convicted of insider trading on the company's stock damaged investors' trust in the biotech firm, saying all its shareholders expect fairness in the market.

40

40

Law 360

AUGUST 18, 2021

Illumina Inc. billion acquisition of Grail, a biotechnology company focused on early-detection cancer testing using DNA, even as the deal faces a legal challenge from the Federal Trade Commission and antitrust scrutiny in Europe. announced Wednesday that it completed its planned $7.1

Legal 40

Legal Legal 40

Conflict of Laws

OCTOBER 21, 2021

The Illumina/Grail merger illustrates this tendency. In March 2021, the FTC challenged the merger and filed an administrative complaint for a temporary restraining order to keep Illumina and Grail from closing the transaction. Specifically, the FTC avers that Illumina’s acquisition of Grail will “lessen competition in the U.S.

Laws 52

Laws Court 52

Patently O

APRIL 15, 2021

Oracle America, Inc., Argument Pending : One final case is set to be argued this term: Minerva Surgical, Inc. Hologic, Inc., In this case, the employee started his own competing company and was sued for patent infringement. Kingston Technology Company, Inc., 20-271; Rovi Guides, Inc. Iancu , No.

Laws 82

Laws Court Technology Manufacturing 82